United States · Pharmaceuticals startup
United States · VERO Biotech
VERO Biotech is a private biotechnology company based in Atlanta, Georgia, founded in 2006.
Funding reportedLast round: Undisclosed round
About VERO Biotech
VERO Biotech is a private biotechnology company based in Atlanta, Georgia, founded in 2006.
The company focuses on developing and commercializing innovative inhaled nitric oxide (iNO) delivery systems to meet the needs of patients with cardiopulmonary conditions. Its flagship product, the GENOSYL® Delivery System, is a tankless platform that generates nitric oxide gas on demand, providing precise dosing and portability for use in various healthcare settings. The GENOSYL® system is FDA-approved and designed for use in neonatal intensive care units, acute care hospitals, operating rooms, and during inter-hospital transport. VERO Biotech also offers the Partnership365TM Service Program, which provides customer support and training to optimize clinical workflows. With a commitment to improving patient outcomes, VERO Biotech aims to enhance the delivery of critical treatments in healthcare facilities.
What company datasets say VERO Biotech raised
Funding, as reported
Founders and team
From the SEC filings it signed: 3 on the team.
- Brent V. FurseExecutive Officer, Directori
- Roberto V. CohenExecutive Officeri
- Shasha V. ZouExecutive Officeri
On the board, as filediDaniel SalazarEric V. BednarskiThiago V. TavaresTodd Brady
On 3 portfolio pages
Investors who name them
Each firm lists VERO Biotech on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
oxygenation improvementhealth caretankless nitric oxide deliverycompact inhaled no systemcassette technologynitric oxide therapyhospital critical care innovationfda-approved inhaled no systemon-demand no deliverymanufacturingportable nitric oxide systemshort half-life nodrug-device combinationneonatestankless delivery systemcardiopulmonary conditions
Built with from their website
Microsoft Azure MonitorDockerCisco Secure Firewall Management CenterGoogle Tag ManagerPaycomOneTrust Tech Risk & ComplianceMicrosoft Advanced Group Policy ManagementWordPress.orgIQMSSalesforce CRM Analytics
+8 more
AtlassianMicrosoft Active Directory Federation ServicesC/C++CloudFlareMicrosoft WindowsViewport MetaCrowdStrike FalconIgnition
- Sector
- Pharmaceuticals
- Industry code
- NAICS 541714, 339112, SIC 3822, 2836, 3841
- Region
- Georgia
- Revenue
- $59M a year, as listed
- Full record
- Every detail in the company directory
Pharmaceuticals in United States
Startups like it
ElevateBioWaltham · founded 2017Raised
SpectronRxIndianapolis · founded 2004Raised
Epirium BioSan Diego · founded 2008Raised
SollisGRANDVIEW · founded 2017Raised
Castle Creek PharmaceuticalsBernards · founded 2015Raised
Bryn PharmaRaleigh · founded 2016Raised
AeroSafe GlobalRochester · founded 1995Raised
AZTherapiesBoston · founded 2011Raised
Is this your company?
Add your raise, your deck and your story, and put VERO Biotech in front of investors. Or tell us what we have wrong.